EP2519230
MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
:
EP einkaleyfi: Þýðing ekki lögð inn:
31.12.2010:
10.10.2018:
10841783.3
:
30.12.2030
:
MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
31.12.2010
10.10.2018
:
Marius Pharmaceuticals LLC:
8601 Six Forks Road, Suite 630, 27615, Raleigh, NC, US
:
DHINGRA, Om:
MorrisvilleNC, US
:
291769 P:
31.12.2009:
US
:
US2010062649:
31.12.2010
:
A61K 9/48, A61K 9/20, A61K 9/22, A61K 31/575, A61K 31/56, A61P 15/00, A61P 15/10, A61K 45/06, A61K 9/107, A61K 31/568, A61K 31/4985, A61K 9/00